Insider Transactions in Q2 2023 at 23and Me Holding Co. (ME)
Insider Transaction List (Q2 2023)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Jun 29
2023
|
Kathy L Hibbs Chief Administrative Officer |
SELL
Open market or private sale
|
Direct |
40,894
-13.72%
|
$40,894
$1.72 P/Share
|
Jun 29
2023
|
Kathy L Hibbs Chief Administrative Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
40,894
+12.07%
|
$0
$0.42 P/Share
|
Jun 05
2023
|
Kenneth J. Hillan Chief Therapeutics Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
15,347
-6.47%
|
$30,694
$2.08 P/Share
|
Jun 05
2023
|
Kenneth J. Hillan Chief Therapeutics Officer |
BUY
Grant, award, or other acquisition
|
Direct |
44,381
+15.76%
|
-
|
Jun 05
2023
|
Kathy L Hibbs Chief Administrative Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
15,098
-5.55%
|
$30,196
$2.08 P/Share
|
Jun 05
2023
|
Kathy L Hibbs Chief Administrative Officer |
BUY
Grant, award, or other acquisition
|
Direct |
43,659
+13.82%
|
-
|
Jun 05
2023
|
Joseph Anthony Selsavage Chief Financial & Actng Ofcr |
SELL
Payment of exercise price or tax liability
|
Direct |
13,075
-4.28%
|
$26,150
$2.08 P/Share
|
Jun 05
2023
|
Joseph Anthony Selsavage Chief Financial & Actng Ofcr |
BUY
Grant, award, or other acquisition
|
Direct |
37,808
+11.0%
|
-
|
May 20
2023
|
Kathy L Hibbs Chief Administrative Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,628
-1.98%
|
$4,628
$1.94 P/Share
|
May 20
2023
|
Kenneth J. Hillan Chief Therapeutics Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,628
-2.34%
|
$4,628
$1.94 P/Share
|
May 20
2023
|
Joseph Anthony Selsavage Chief Financial & Actng Ofcr |
SELL
Payment of exercise price or tax liability
|
Direct |
6,209
-2.26%
|
$6,209
$1.94 P/Share
|